Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 1;35(9):769-81.
doi: 10.1007/BF03261973.

Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study

Affiliations

Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study

Chen Wu et al. Drug Saf. .

Abstract

Background: The rapid rise in the availability and use of pharmaceutical agents, and particularly polypharmacy, directly increases the risk for patients to experience adverse drug reactions (ADRs). There are few studies on the overall incidence and costs of ADRs.

Objective: The aim of this study was to estimate the incidence and costs of emergency department (ED) visits related to ADRs for patients greater than 65 years of age using administrative data, and to describe risk factors for experiencing severe ADRs.

Methods: We employed a retrospective cohort design based on population-based healthcare administrative clinical databases. Identification of ADR-related ED visits from the administrative database was based on International Classification of Diseases, 10th Revision-Canadian Enhancement (ICD-10-CA) codes for each ED visit. The incidence and costs of ADR-related ED visits and subsequent hospital admissions were estimated for all adults aged 66 years and above for the period April 2003-March 2008. Costs were standardized and reported in 2008 Canadian dollars. Logistic regression was used to detect risk factors for severe ADRs.

Results: Approximately 0.75% of total annual ED visits among adults aged 66 years and above were found to be ADR-related, and among these patients 21.6% were hospitalized. In 2007, the cost of ADR-related visits was $333 per ED visit and $7528 per hospitalization for a total annual cost of $13.6 million in Ontario, or an estimated $35.7 million in Canada. Severe ADRs were associated with sex, age, comorbid disease burden, multiple drugs, multiple pharmacies, newly prescribed drugs, recent ED visit, recent hospitalization and long-term care (LTC) residence.

Conclusions: ADRs are an important public health issue that threaten the safety of drug therapy and results in significant economic burden to the healthcare system. ED visits related to ADRs may be underestimated in retrospective studies using administrative data compared with prospective studies. Further research is needed to better understand the risk of experiencing severe ADRs among LTC residents.

PubMed Disclaimer

Figures

Table I
Table I
Total number of emergency department visits for which there was a diagnosis or external cause for adverse drug reactions 2003–7
Table II
Table II
Outcome of patients who had adverse drug reaction-related emergency department visits
Table III
Table III
Costs of adverse drug reaction-related emergency department visits and subsequent hospital admissionsa
Table IV
Table IV
Characteristics of patients having adverse drug reaction-related emergency department visits in 2007
Table V
Table V
Characteristics of patients having adverse drug reaction-related emergency department visits in 2007 according to the severity of the adverse drug reactionsa
Table VI
Table VI
Odds ratio of risk factors for experiencing severe adverse drug reactions

References

    1. WHO International drug monitoring: the role of the national centers. World Health Organ Tech Rep Ser. 1972;498:1–25. - PubMed
    1. Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5. doi: 10.1001/jama.279.15.1200. - DOI - PubMed
    1. Onder G., Pedone C., Landi F., et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA. J Am Geriatr Soc. 2002;50(12):1962–8. doi: 10.1046/j.1532-5415.2002.50607.x. - DOI - PubMed
    1. Patel H., Bell D., Molokhia M., et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005. BMC Clin Pharmacol. 2007;7:9. doi: 10.1186/1472-6904-7-9. - DOI - PMC - PubMed
    1. Dormann H., Criegee-Rieck M., Neubert A., et al. Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma. Drug Saf. 2003;26(5):353–62. doi: 10.2165/00002018-200326050-00004. - DOI - PubMed

Publication types

Substances